GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MyunMoon Pharm Co Ltd (XKRX:017180) » Definitions » Total Debt per Share

MyunMoon Pharm Co (XKRX:017180) Total Debt per Share : ₩2,690.58 (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is MyunMoon Pharm Co Total Debt per Share?

₩2,690.58 (As of Sep. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. MyunMoon Pharm Co's Total Debt Per Share for the quarter that ended in Sep. 2024 was ₩2,690.58.

MyunMoon Pharm Co Total Debt per Share Historical Data

The historical data trend for MyunMoon Pharm Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyunMoon Pharm Co Total Debt per Share Chart

MyunMoon Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,699.91 2,922.39 2,488.64 2,459.85 2,698.77

MyunMoon Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,647.02 2,698.77 2,652.31 2,777.84 2,690.58

MyunMoon Pharm Co Total Debt per Share Calculation

MyunMoon Pharm Co's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(13,044+77,438)/34
=2,698.77

MyunMoon Pharm Co's Total Debt Per Share for the quarter that ended in Sep. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(35,216+54,725)/33
=2,690.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MyunMoon Pharm Co Total Debt per Share Related Terms

Thank you for viewing the detailed overview of MyunMoon Pharm Co's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

MyunMoon Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MyunMoon Pharm Co Ltd (XKRX:017180) » Definitions » Total Debt per Share
Comparable Companies
XKRX:044960 XKRX:229500 XKRX:053950 XKRX:239610 XKRX:175250 XKRX:007370 XKRX:260660 XKRX:041910 XKRX:200230 XKRX:000220 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
946-18 Dokok-Dong, Kangnam-ku, Seoul, KOR, 135-270
Website
http://www.mmpharm.co.kr
MyunMoon Pharm Co Ltd is a South Korea based company engages in the manufacture and sale of pharmaceutical products. Its products include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs, and others.

MyunMoon Pharm Co Headlines

No Headlines